Experimental browser for the Atmosphere
Semaglutide treats liver disease in two thirds of patients, new research has found. Results from the ESSENCE phase 3 clinical trial shows treating patients with the substance can halt and even reverse the disease. @kingslsm.bsky.social www.kcl.ac.uk/news/semaglu...
May 1, 2025, 10:18 AM
{ "uri": "at://did:plc:msp6cc4ee6otgerstkxadnay/app.bsky.feed.post/3lo43hblcc22s", "cid": "bafyreicf7w2n3t2yz6nfv7rvicknsjv7bz3nhlgpy72xkx4g2c5ref746q", "value": { "text": "Semaglutide treats liver disease in two thirds of patients, new research has found.\n \nResults from the ESSENCE phase 3 clinical trial shows treating patients with the substance can halt and even reverse the disease.\n \n@kingslsm.bsky.social\n \nwww.kcl.ac.uk/news/semaglu...", "$type": "app.bsky.feed.post", "embed": { "$type": "app.bsky.embed.external", "external": { "uri": "https://www.kcl.ac.uk/news/semaglutide-treats-liver-disease-in-two-thirds-of-patients", "thumb": { "$type": "blob", "ref": { "$link": "bafkreic5ul3zx22kdg42mr3ho6gjpgrmp5ggszqfvugu4uaozzmo7gvfxe" }, "mimeType": "image/jpeg", "size": 906184 }, "title": "Semaglutide treats liver disease in two thirds of patients", "description": "Semaglutide effectively treats liver disease in two thirds of patients, new research has found." } }, "langs": [ "en" ], "facets": [ { "$type": "app.bsky.richtext.facet", "index": { "byteEnd": 239, "byteStart": 218 }, "features": [ { "did": "did:plc:6pbtsdrrqnzmcpnw3ggt7tmf", "$type": "app.bsky.richtext.facet#mention" } ] }, { "index": { "byteEnd": 271, "byteStart": 242 }, "features": [ { "uri": "https://www.kcl.ac.uk/news/semaglutide-treats-liver-disease-in-two-thirds-of-patients", "$type": "app.bsky.richtext.facet#link" } ] } ], "createdAt": "2025-05-01T10:18:22.240Z" } }